AstraZeneca PLC is 98.3x more valuable than Dyne Therapeutics, Inc. by market capitalization ($286.27 B vs $2.91 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DYN | AZN |
|---|---|---|
| Market cap | $2.91 B | $286.27 B |
| US-listed rank | #1828 | #45 |
| Net income (latest FY) | -$446.20 | - |
| SEC filings | 710 | 1,004 |
AstraZeneca PLC is 98.3x more valuable than Dyne Therapeutics, Inc. by market capitalization ($286.27 B vs $2.91 B).
Full pages: Dyne Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.